Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells. - Wikidata - wikimedia - TriplyDB

Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells.

Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells.

http://www.wikidata.org/entity/Q42230042

about

Roles of resolvins in the resolution of acute inflammation The specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant?The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation The effects of diet-induced obesity on B cell function Resolution of acute inflammation in the lung Cutting edge: Parathyroid hormone facilitates macrophage efferocytosis in bone marrow via proresolving mediators resolvin D1 and resolvin D2.Pro-resolving lipid mediators are leads for resolution physiology.Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss.The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages.Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation.Short-term consumption of n-3 PUFAs increases murine IL-5 levels, but IL-5 is not the mechanistic link between n-3 fatty acids and changes in B-cell populations Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents DHA-enriched fish oil targets B cell lipid microdomains and enhances ex vivo and in vivo B cell function Group X Secreted Phospholipase A2 Releases ω3 Polyunsaturated Fatty Acids, Suppresses Colitis, and Promotes Sperm Fertility Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators Dual Roles of Group IID Phospholipase A2 in Inflammation and Cancer n-3 PUFAs enhance the frequency of murine B-cell subsets and restore the impairment of antibody production to a T-independent antigen in obesity.Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial Intravenous fish oil lipid emulsion promotes a shift toward anti-inflammatory proresolving lipid mediators.N-3 fatty acids and membrane microdomains: from model membranes to lymphocyte function.N-3 polyunsaturated fatty acids modulate B cell activity in pre-clinical models: Implications for the immune response to infections.Lipoxin A₄ modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism.New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.Regulation of inflammation by lipid mediators in oral diseases.Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.B Cell Activity Is Impaired in Human and Mouse Obesity and Is Responsive to an Essential Fatty Acid upon Murine Influenza Infection.Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes.Fish oil disrupts MHC class II lateral organization on the B-cell side of the immunological synapse independent of B-T cell adhesion Bioactive Lipids and Chronic Inflammation: Managing the Fire Within.Effects of fish oils on ex vivo B-cell responses of obese subjects upon BCR/TLR stimulation: a pilot study.Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery.Interrelation of Diet, Gut Microbiome, and Autoantibody Production.Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines.Role of the Specialized Proresolving Mediator Resolvin D1 in Systemic Lupus Erythematosus: Preliminary Results

P2860

Q28244502-6F43A9F6-9FFC-4CC8-8FA6-AEFCD815BAC1 Q28251512-371AC637-7205-44B2-8C6C-FE433950034E Q28260186-DEB13B9B-BCC7-4B7E-A234-393655F9FD7B Q28268731-51B6FE8E-DF40-4F39-9F3F-BC59408A474A Q28269550-6D38477A-9F66-4C8C-B034-3E86BD73D6B3 Q28383934-177F8B3D-23EF-4024-BC23-28FA3117EB01 Q28652204-4DE4F179-229D-42AB-9D13-445010C8E050 Q30613107-7E83FA3C-5009-4340-9899-323E86D58C97 Q30829097-B0ABD55F-7D85-46B4-B992-CA4A9DC64EC2 Q33882297-A2E66932-5F76-496F-AFA2-6B0DD9968B50 Q34230865-5997AC69-1688-4E0A-84B7-1B600A04AD77 Q35744344-0DD0E77E-6879-4DEE-B3EB-F4B72F310A23 Q36174560-89798C95-B65B-4B58-BF17-1FE4BD3F6B45 Q36196850-462A0B34-7FE8-4211-84ED-6F2C46520219 Q36591336-298AEAA3-B693-437C-85CF-0309D0781A3A Q36642003-A94B92DE-A357-4174-8403-E305157BFBE5 Q36685283-F440DA87-627F-41A0-9FBA-4E5626F6C7F7 Q36727399-51C7EF3C-50F9-49E1-A390-1CE2E19E778F Q36907943-23A43C92-9B21-4E76-AC89-7A7710591C2E Q37117284-5A19DFF4-6526-4813-B8D3-4E430FFC9BF7 Q37222703-A14EC973-5B36-4595-92DF-BD8CF847CC81 Q37363551-86871367-B40D-442E-A320-4FAE1F4D97D1 Q37440091-EA1631BB-2DC0-4A44-A97B-387D2937D0A3 Q38056225-D3A2E16D-EA12-4256-A57D-13578C4C9168 Q38506789-D4AAE9BA-39B0-4E99-8407-DE875FEBA7CF Q38532763-CA2E7F77-01D8-491B-8C00-1958E97D3C46 Q38627502-81615BAC-A6AD-4574-803E-7E4278E9E42F Q38899898-6420A3D1-19D4-4E63-9479-641930E8331B Q39088075-8645A60D-9A4E-42B0-B8B3-5908B8866058 Q39197238-57449571-778B-47B2-B37D-EED0C622298F Q40214715-99E3CFC5-A2CF-486C-A570-5E08E303D6AC Q40956866-D1294C38-EEEB-4A78-A772-33B3C1A710BC Q41903985-0DE98A39-4B8D-451B-A1F3-F9EA7F523A02 Q49679435-0E606AAB-F8E9-4341-93FA-36F319AD2F97 Q50547445-46D98D59-DD0A-4ECE-975C-EB52B41E7331 Q52369219-B1B190D4-D5DB-4F5D-B399-083DA4910680 Q55043186-64317D0A-C1E8-4C1F-AC13-FBD44A06199E Q55057811-3D0D0205-2243-4A03-ADEF-2B6F1B541AB1 Q58695131-097933A4-3F58-4D72-AB67-5A7EDB320917

P2860

Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells.

http://www.wikidata.org/entity/Q42230042

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Specialized proresolving media ...... n to antibody-secreting cells.

@en

Specialized proresolving media ...... n to antibody-secreting cells.

@nl

type

label

Specialized proresolving media ...... n to antibody-secreting cells.

@en

Specialized proresolving media ...... n to antibody-secreting cells.

@nl

prefLabel

Specialized proresolving media ...... n to antibody-secreting cells.

@en

Specialized proresolving media ...... n to antibody-secreting cells.

@nl

P1433

Q42230042-8E4F3A5C-9659-4116-8310-34684FF9A489

P1476

Q42230042-3C5D69C6-809A-4910-9172-7F56287C0398

P2093

Q42230042-3C071D23-E2CD-4331-BF16-946280BBB277

Q42230042-991823F7-CA58-40E2-A4E7-2040E5054ABE

Q42230042-DA2CC6CF-74E1-4544-A3C1-801329926EB2

Q42230042-DBB115F7-38D4-453B-A8AD-D26366408610

P2860

Q42230042-0D4D3446-8344-46FC-946B-5462782B8003

Q42230042-0DA632F0-FF57-4733-8A0C-DCBC83F086B6

Q42230042-1B4A83F7-2568-4E68-A737-CF3AC0ACF128

Q42230042-1B4F80DF-A2C8-4573-928A-140721444A28

Q42230042-1D72442B-3BEA-4224-A51C-E7BA4FB74F44

Q42230042-21B6CADA-A90D-407A-BABA-D3F7E03B548B

Q42230042-26814479-AE04-42E4-BEDA-10CD8877610C

Q42230042-26C0C5D2-9CF6-411B-92BA-FB2311886CF5

Q42230042-33CD0D4F-2AC4-459B-A000-C4717DD22380

Q42230042-409369BC-B7E4-443B-9ECF-62EEB410DB3F

P304

Q42230042-3596FC42-FB8F-4D96-905B-E01B29B53599

P31

Q42230042-B95AA8A1-2564-488F-BE31-4BAE95506E61

P356

Q42230042-53C49E0C-1BB4-4418-B8E9-083BE135FA3B

P407

Q42230042-874664E6-4333-4E8C-B7C5-B31938F5173A

P433

Q42230042-4971C8FF-2953-439B-93D5-F0465A560587

P478

Q42230042-367D29EC-C271-47C2-9AC6-A6E3490F63DE

P577

Q42230042-2495BA88-9E29-4587-B975-9AEB835A6C18

P5875

Q42230042-6289397E-0493-4825-A89D-D3572F37DECE

P698

Q42230042-70B65911-FB1F-43DB-B397-1DFD2DA3FE12

P921

Q42230042-CBBB391C-7CF7-4E87-BD91-E37F1603F083

P932

Q42230042-A35BC725-E253-491C-B035-5CC25F526100

P356

JIMMUNOL.1103483

P1433

Journal of Immunology

P1476

Specialized proresolving media ...... n to antibody-secreting cells.

@en

P2093

Charles N Serhan

http://www.w3.org/2001/XMLSchema#string

Fei Gao

http://www.w3.org/2001/XMLSchema#string

Richard P Phipps

http://www.w3.org/2001/XMLSchema#string

Sesquile Ramon

http://www.w3.org/2001/XMLSchema#string

P2860

Plasma cell differentiation requires the transcription factor XBP-1

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution

Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins

Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells

Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis

Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production.

Detection and cellular localization of 12R-lipoxygenase in human tonsils.

P304

1036-1042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1103483

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227343754

http://www.w3.org/2001/XMLSchema#string

P698

22711890

http://www.w3.org/2001/XMLSchema#string

P921

P932

3392531

http://www.w3.org/2001/XMLSchema#string